Exelixis Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
254,666.00
156,497.00
167,060.00
419,803.00
388,275.00
693
Total Accounts Receivable
3,941.00
4,882.00
5,183.00
40,444.00
81,192.00
179
Inventories
2,890.00
2,381.00
2,616.00
3,338.00
6,657.00
10
Other Current Assets
5,112.00
3,481.00
3,806.00
5,416.00
8,750.00
15
Total Current Assets
266,609.00
167,241.00
178,665.00
469,001.00
484,874.00
897
Net Property, Plant & Equipment
4,910.00
2,432.00
1,434.00
2,071.00
25,743.00
57
Total Investments and Advances
161,196.00
86,263.00
86,250.00
59,751.00
68,901.00
158
Intangible Assets
63,684.00
63,684.00
63,684.00
63,684.00
63,684.00
64
Other Assets
6,888.00
8,340.00
2,309.00
1,232.00
12,092.00
2
Total Assets
503,287.00
327,960.00
332,342.00
595,739.00
655,294.00
1,424
ST Debt & Current Portion LT Debt
11,762.00
99,261.00
-
189,122.00
-
Accounts Payable
9,345.00
6,413.00
6,401.00
6,565.00
9,575.00
Other Current Liabilities
66,746.00
66,186.00
45,850.00
73,099.00
105,595.00
Total Current Liabilities
87,853.00
171,860.00
52,251.00
268,786.00
115,170.00
Long-Term Debt
335,475.00
262,395.00
417,937.00
-
-
Provision for Risks & Charges
9,047.00
4,365.00
-
-
-
Other Liabilities
4,674.00
4,169.00
2,960.00
237,635.00
255,163.00
Total Liabilities
437,049.00
442,789.00
473,148.00
506,421.00
370,333.00
Common Equity (Total)
66,238.00
114,829.00
140,806.00
89,318.00
284,961.00
Total Shareholders' Equity
66,238.00
114,829.00
140,806.00
89,318.00
284,961.00
Total Equity
66,238.00
114,829.00
140,806.00
89,318.00
284,961.00
Liabilities & Shareholders' Equity
503,287.00
327,960.00
332,342.00
595,739.00
655,294.00

About Exelixis

View Profile
Address
1851 Harbor Bay
Parkway Alameda California 94502
United States
Employees -
Website http://www.exelixis.com
Updated 07/08/2019
Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S.